COVID-19 Puts Spotlight On Clinical Trial Networks: 'We Really Need Them Right Now'
Duke-Margolis' Mark McClellan touts the advantages networks have over individual operations, citing the dexamethasone RECOVERY trial, and notes need for real-world evidence infrastructure.